Applied Therapeutics, Inc. Accounts Payable
Applied Therapeutics, Inc. had Accounts Payable of $4.80 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-13
- 2025-09-30: Accounts Payable, Current $4.80M.
- 2025-06-30: Accounts Payable, Current $4.86M.
- 2025-03-31: Accounts Payable, Current $4.87M.
- 2024-12-31: Accounts Payable, Current $4.43M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-30 | $4.80M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.86M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.87M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.43M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $2.84M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.68M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $4.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.74M 10-K · filed 2025-04-15 |
| 2023-09-30 | $6.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.69M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.55M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.53M 10-K · filed 2024-03-06 |
| 2022-09-30 | $6.97M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.69M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $5.92M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.46M 10-K · filed 2023-03-23 |
| 2021-09-30 | $9.17M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.31M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.48M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $640.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.95M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $5.65M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.61M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.79M 10-K · filed 2021-03-18 |
| 2019-09-30 | $1.69M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.99M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.65M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $3.02M 10-K · filed 2020-03-13 |